Finance

Lists
Why is OCUL down 4,95%?
Dive Deeper
OCUL:NASDAQ
Ocular Therapeutix Inc
5,57 $
-4,95%
(-0,29) 1D
5,60 $
+0,54% (+0,030)
After hours
Closed: 20 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
5,76 $
High
5,95 $
Low
5,54 $
Mkt. cap
1,23 մլրդ
Avg. vol.
2,99 մլն
Volume
2,90 մլն
52-wk high
16,44 $
52-wk low
5,54 $
EPS
-1,46 $
Beta
1,22
Shares outstanding
220,02 մլն
No. of employees
325
Open
5,76 $
High
5,95 $
Low
5,54 $
Mkt. cap
1,23 մլրդ
Avg. vol.
2,99 մլն
Volume
2,90 մլն
52-wk high
16,44 $
52-wk low
5,54 $
EPS
-1,46 $
Beta
1,22
Shares outstanding
220,02 մլն
No. of employees
325
News stories
From web sources and news partners
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, Մասսաչուսեթս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websiteocutx.com
Analyst ratings
Based on 7 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current 5,57 $
31,00 $ (+456,55%)
Average
24,67 $ (+342,91%)
Lowest
14,00 $ (+151,35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
28,00 $
+402,7%
11/17/2026
Serge Belanger
Needham
Buy
Maintained
18,00 $
+223,2%
11/10/2026
Lisa Walter
RBC Capital
Buy
Reiterated
30,00 $
+438,6%
11/09/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
27,00 $
+384,7%
11/09/2026
Biren Amin
Piper Sandler
Buy
Maintained
31,00 $
+456,6%
10/12/2026
Unknown Analyst
UBS
Buy
Initiated
14,00 $
+151,3%
10/11/2026
Alice Nettleton
UBS
Buy
Initiated
14,00 $
+151,3%
10/11/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/25/2026
William Maughan
Clear Street
Buy
Reiterated
28,00 $
+402,7%
08/18/2026
Tara Bancroft
TD Cowen
Buy
Maintained
20,00 $
+259,1%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
23,00 $
+312,9%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
30,00 $
+438,6%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
28,00 $
+402,7%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
13,25 մլն
10,78 մլն
13,48 մլն
12,87 մլն
Cost of goods sold
52,39 մլն
67,54 մլն
56,15 մլն
76,24 մլն
Cost of revenue
52,39 մլն
67,54 մլն
56,15 մլն
76,24 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30,62 մլն
36,58 մլն
39,44 մլն
34,49 մլն
Operating expense
30,62 մլն
36,58 մլն
39,44 մլն
34,49 մլն
Total operating expenses
83,01 մլն
104,12 մլն
95,58 մլն
110,73 մլն
Operating income
-69,76 մլն
-93,34 մլն
-82,11 մլն
-97,86 մլն
Other non operating income
624,00 հզր
1,46 մլն
689,00 հզր
912,00 հզր
EBT including unusual items
-64,65 մլն
-88,61 մլն
-78,76 մլն
-94,78 մլն
EBT excluding unusual items
-64,62 մլն
-88,61 մլն
-78,76 մլն
-94,78 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64,65 մլն
-88,61 մլն
-78,76 մլն
-94,78 մլն
Net profit margin
-487,95%
-821,62%
-584,51%
-736,23%
Earnings per share
-0,29
-0,40
-0,35
-0,42
Interest and investment income
7,34 մլն
6,05 մլն
5,45 մլն
4,98 մլն
Interest expense
-2,83 մլն
-2,78 մլն
-2,79 մլն
-2,81 մլն
Net interest expenses
4,51 մլն
3,27 մլն
2,66 մլն
2,16 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-68,51 մլն
-92,06 մլն
-80,26 մլն
-95,43 մլն
Gain or loss from assets sale
-
4,87 մլն
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps